Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3102 ARTÍCULOS , VIENDO DEL 676 AL 690

Relative effectiveness assessment of listed drugs (REAL): a new method for an early comparison of the effectiveness of approved health technologies

Falissard B, Izard V, Xerri B, Bouvenot G, Meyer F, Degos L.

Int J Technol Assess Health Care. 2010 Jan;26(1):124-30. doi: 10.1017/S0266462309990821.

Influenza caused epidemic encephalitis (encephalitis lethargica): the circumstantial evidence and a challenge to the nonbelievers

Maurizi CP.

Med Hypotheses. 2010 May;74(5):798-801. doi: 10.1016/j.mehy.2009.12.012. Epub 2010 Jan 8.

Neuronal histamine and the interplay of memory, reinforcement and emotions

Dere E, Zlomuzica A, De Souza Silva MA, Ruocco LA, Sadile AG, Huston JP.

Behav Brain Res. 2010 Dec 31;215(2):209-20. doi: 10.1016/j.bbr.2009.12.045. Epub 2010 Jan 8.

Alanine-to-threonine substitutions and amyloid diseases: butyrylcholinesterase as a case study

Podoly E, Hanin G, Soreq H.

Chem Biol Interact. 2010 Sep 6;187(1-3):64-71. doi: 10.1016/j.cbi.2010.01.003. Epub 2010 Jan 11.

Conjugal parkinsonism: multiple system atrophy and Parkinson's disease

Miwa H, Kondo T.

Parkinsonism Relat Disord. 2010 Mar;16(3):232. doi: 10.1016/j.parkreldis.2009.12.009. Epub 2010 Jan 12.

Muscular pain in Parkinson's disease and nociceptive processing assessed with CO2 laser-evoked potentials

Tinazzi M, Recchia S, Simonetto S, Tamburin S, Defazio G, Fiaschi A, Moretto G, Valeriani M.

Mov Disord. 2010 Jan 30;25(2):213-20. doi: 10.1002/mds.22932.

Artistic profession: a potential risk factor for dopamine dysregulation syndrome in Parkinson's disease?

Schwingenschuh P, Katschnig P, Saurugg R, Ott E, Bhatia KP.

Mov Disord. 2010 Mar 15;25(4):493-6. doi: 10.1002/mds.22936.

Skin cancer and Parkinson's disease

Ferreira JJ, Neutel D, Mestre T, Coelho M, Rosa MM, Rascol O, Sampaio C.

Mov Disord. 2010 Jan 30;25(2):139-48. doi: 10.1002/mds.22855.

Parkinsonism in patients with a history of amphetamine exposure

Christine CW, Garwood ER, Schrock LE, Austin DE, McCulloch CE.

Mov Disord. 2010 Jan 30;25(2):228-31. doi: 10.1002/mds.22915.

Orodispersible sublingual piribedil to abort OFF episodes: a single dose placebo-controlled, randomized, double-blind, cross-over study

Rascol O, Azulay JP, Blin O, Bonnet AM, Brefel-Courbon C, Césaro P, Damier P, Debilly B, Durif F, Galitzky M, Grouin JM, Pennaforte S, Villafane G, Yaici S, Agid Y.

Mov Disord. 2010 Feb 15;25(3):368-76. doi: 10.1002/mds.22922.

Subthalamic nucleus stimulation affects fear and sadness recognition in Parkinson's disease

Péron J, Biseul I, Leray E, Vicente S, Le Jeune F, Drapier S, Drapier D, Sauleau P, Haegelen C, Vérin M.

Neuropsychology. 2010 Jan;24(1):1-8. doi: 10.1037/a0017433.

Evidence for motor learning in Parkinson's disease: acquisition, automaticity and retention of cued gait performance after training with external rhythmical cues

Rochester L, Baker K, Hetherington V, Jones D, Willems AM, Kwakkel G, Van Wegen E, Lim I, Nieuwboer A.

Brain Res. 2010 Mar 10;1319:103-11. doi: 10.1016/j.brainres.2010.01.001. Epub 2010 Jan 11.

Effects of a dopamine agonist on the pharmacodynamics of levodopa in Parkinson disease

Brodsky MA, Park BS, Nutt JG.

Arch Neurol. 2010 Jan;67(1):27-32. doi: 10.1001/archneurol.2009.287.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias